Cognition Therapeutics funds its research efforts through grants as well as through investments by a committed investor syndicate. To date, Cognition has raised $44 million in non-dilutive grants from the National Institute on Aging (NIA), part of the NIH, as well as from foundations such as the Alzheimer's Drug Discovery Foundation (ADDF). Additional capital has been raised by angel and venture investors.

The Alzheimer’s Drug Discovery Foundation funds promising, innovative drugs to prevent and treat Alzheimer’s disease and related dementias. A full 100% of every dollar donated goes directly to fund research.

Bios Partners focuses on early stage private healthcare investments throughout the South and Mid-West. Bios provides its portfolio companies with strategy, fractional CFO services, capital investment and access into the capital markets.

Dolby Family Ventures is an early stage venture firm focused on building great technology companies. They partner with best-in-class innovators and strong investment syndicate partners at the seed stage of a company’s development.

Golden Seeds has over 275 investors and several venture funds. Since 2005, they have invested over $70 million in more than 65 women-led enterprises. Golden Seeds is headquartered in New York City and also has chapters in Boston, Silicon Valley, Southern California and Texas.

Ogden CAP assists individuals, families, and small to mid-sized business owners with managing their finances and investments, with an emphasis on personalized client service and performance. Their investment philosophy focuses on customized financial planning, asset management, and asset allocation.

The Pittsburgh Life Sciences Greenhouse (PLSG) is a nationally recognized economic development, investment, business incubator firm committed to empowering entrepreneurs to build innovative and successful life sciences companies.

The mission of the NIA is to improve the health and well-being of older Americans through biomedical, social and behavioral research. Within NIA, the Division of Neuroscience fosters and supports extramural research and training to further the understanding of Alzheimer’s disease and other dementias of old age as well as the neural and behavioral processes associated with the normally aging brain.

Scroll to Top